← Eichor
Condition: Gene Mutation Related Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gene Mutation Related Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Phase 1 · 40 location(s) · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06625775Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Phase N/A · 2 location(s) · National Cancer Institute (NCI) · NCT01247597PRE-I-SPY Phase I/Ib Oncology Platform Program
Phase 1 · 7 location(s) · QuantumLeap Healthcare Collaborative · NCT05868226Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05769517XL092 and Cemiplimab in BRAF WT Thyroid Cancer
Phase 1 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06902376An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Inte
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05420064PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
Phase 1 · 5 location(s) · Pasithea Therapeutics Corp. · NCT06961565Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.
NA · 5 location(s) · Institut Claudius Regaud · NCT06022016Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
Phase N/A · 2 location(s) · Simons Searchlight · NCT01238250Personalized NK Cell Therapy in CBT
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT02727803Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Phase N/A · 2 location(s) · University of Geneva, Switzerland · NCT05512169NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors
Phase 1 · 1 location(s) · Georgetown University · NCT05661201Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Phase N/A · 1 location(s) · Zhiping Wang · NCT07589413A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT01994057Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer
Phase N/A · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05466786Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers
Phase N/A · 20 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06408402A Phase 1/1b Study of IAM1363 in HER2 Cancers
Phase 1 · 53 location(s) · Iambic Therapeutics, Inc · NCT06253871Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherap
Phase 1/Phase 2 · 4 location(s) · Auricula Biosciences Inc. · NCT07148128Genetic Information Assistant in Telegenetics
NA · 1 location(s) · University of Virginia · NCT06089421CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
Phase N/A · 27 location(s) · University Health Network, Toronto · NCT04151342COsegregation of VARiants in Panel of Genes
NA · 62 location(s) · Institut Curie · NCT01689584A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
Phase 2 · 2 location(s) · Murdoch Childrens Research Institute · NCT05983159Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis
Phase N/A · 2 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06781242Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
Phase 1/Phase 2 · 1 location(s) · University of California, Irvine · NCT07064018Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL
NA · 1 location(s) · Pamukkale University · NCT07154043RASopathy Biorepository
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT04395495EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
NA · 6 location(s) · Dana-Farber Cancer Institute · NCT06716580Determining Individualized Cancer Therapy in Pancreatic Cancer
Phase N/A · 1 location(s) · Medical College of Wisconsin · NCT05914987
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.